Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$3.2 - $4.19 $144,060 - $188,629
-45,019 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.8 - $4.22 $7,971 - $12,014
-2,847 Reduced 5.95%
45,019 $154,000
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $154,128 - $212,046
47,866 New
47,866 $178,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $376M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.